角膜穿孔及变薄患者行胶水黏合后需行穿透性角膜移植的临床结局与预测因素
单中心回顾性队列纳入2006年1月至2024年8月因角膜变薄或穿孔接受氰基丙烯酸酯组织黏合剂(CTA)治疗的189眼,64眼(34%)后续行穿透性角膜移植(PKP)。多因素回归显示中央或旁中央缺损、多次CTA、基线视力差及病毒性角膜炎为PKP独立预测因素,外伤与PKP风险降低相关;PKP后最终视力中位数2.0 logMAR,与基线无显著差异。
要点
- 189眼CTA治疗后64眼(34%)需行PKP。
- 中央或旁中央缺损、多次CTA、基线BCVA差及病毒性角膜炎与PKP风险升高独立相关。
- 外伤与PKP风险降低相关;PKP后最终BCVA中位数2.0 logMAR,与基线无显著差异。
核心结论
- PKP仍是CTA治疗无效眼的重要干预手段,但最终视力结局有限。
- 早期识别高风险临床特征可能有助于指导及时决策并设定合理的预后预期。
研究设计与样本
- 回顾性临床队列研究,单中心,纳入2006年1月至2024年8月因角膜变薄或穿孔接受CTA治疗的189眼。
- 主要结局为末次随访时最佳矫正视力(BCVA),采用单变量和多变量逻辑回归分析基线及临床特征与CTA后进展至PKP的关联。
主要发现
- 189眼中64眼(34%)在CTA后行PKP。
- 多变量回归显示中央或旁中央缺损(vs周边,OR=2.98,95%CI=1.27-6.91,P=.012)、多次CTA(vs单次,OR=2.70,95%CI=1.42-5.15,P=.003)、基线BCVA较差(logMAR>2 vs logMAR<1,OR=3.10,95%CI=1.35-6.58,P=.005)及病毒性角膜炎(OR=3.55,95%CI=1.21-9.58,P=.020)为需行PKP的独立预测因素。
- 外伤与PKP风险降低相关(OR=0.26,95%CI=0.08-0.80,P=.014)。
- PKP后最终BCVA中位数为2.0 logMAR(IQR:1.5-2.3),与基线无显著差异(P=.585)。
临床怎么用
- 作者认为,早期识别高风险临床特征可能有助于指导及时决策并设定合理的预后预期。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To describe the clinical outcomes and identify predictive factors associated with the need for penetrating keratoplasty (PKP) following cyanoacrylate tissue adhesive (CTA) application for corneal perforation or thinning. DESIGN: Retrospective clinical cohort study. METHODS: We conducted a single-center, retrospective cohort study of 189 eyes treated with CTA for corneal thinning or perforation between January 2006 and August 2024 at a tertiary care center. The primary outcome was the best-corrected visual acuity (BCVA) at final follow-up. Univariable and multivariable logistic regression models were used to identify associations between baseline and clinical characteristics with progression to PKP following CTA management. RESULTS: Of 189 eyes treated with CTA, 64 (34%) underwent subsequent PKP after CTA application. Multivariable regression identified several independent predictors of needing PKP, including central or paracentral defect location (vs peripheral, OR = 2.98, 95% CI = 1.27-6.91, P = .012), multiple CTA applications (vs single, OR = 2.70, 95% CI = 1.42-5.15, P = .003), worse baseline BCVA (logMAR >2 vs logMAR <1; OR = 3.10, 95% CI = 1.35-6.58, P = .005), and viral keratitis (OR = 3.55, 95% CI = 1.21-9.58, P = .020). Trauma was associated with lower odds of PKP (OR = 0.26, 95% CI = 0.08-0.80, P = .014). Median final BCVA following PKP was 2.0 logMAR (IQR: 1.5-2.3), with no significant difference from baseline (P = .585). CONCLUSION: PKP remains an important intervention for eyes refractory to CTA; however, final visual outcomes are limited. Early identification of high-risk clinical features may help guide timely decision-making and set realistic expectations regarding prognosis.
引用
- Agarwal M, Huang RS, Mimouni M, et al. Clinical Outcomes and Predictive Factors for Penetrating Keratoplasty Following Glue Application for Corneal Perforation and Thinning. Am J Ophthalmol. 2025. PMID: 40829700. doi:10.1016/j.ajo.2025.08.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。